top of page

Dr David Erritzøe

A Clinical Senior Lecturer and Consultant Psychiatrist at Imperial College London

Since 2009, David has been involved in post-doc imaging research in the neurobiology of addictions and major depression. As clinical director in the Centre for Psychedelic Research, he investigates mechanisms and therapeutic potential of MDMA, ketamine and classic psychedelics together with Prof David Nutt and Dr Robin Carhart-Harris, and in early 2021 David set up a new NHS-based psychopharmacology & psychedelic research clinic at St Charles Hospital in London.

bottom of page